Congenital abnormalities and acute leukemia among children with Down syndrome: a Children's Oncology Group study

Area of Science:

• Pediatric Oncology
• Genetics
• Epidemiology

Background:

• Children with Down syndrome have a higher risk of leukemia and congenital abnormalities.
• Understanding leukemia etiology in this population is crucial.

Purpose of the Study:

• To investigate the association between congenital abnormalities and acute leukemia in children with Down syndrome.
• To determine if congenital malformations confer additional leukemia risk beyond trisomy 21.

Main Methods:

• A Children's Oncology Group study interviewed mothers of 158 cases (children with Down syndrome and leukemia) and 173 controls.
• Unconditional logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (95% CI).
• Analyses were performed for acute leukemia overall, and separately for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).

Main Results:

• No significant association was found between congenital abnormalities and acute leukemia in index children (OR=0.74) or their siblings (OR=1.23).
• Specific analyses for ALL (OR=0.67 for index children, OR=1.12 for siblings) and AML (OR=1.03 for index children, OR=1.60 for siblings) also showed no significant increased risk.
• The results suggest that congenital malformations do not add to the leukemia risk already elevated by trisomy 21.

Conclusions:

• Congenital abnormalities do not appear to be an independent risk factor for childhood leukemia in individuals with Down syndrome.
• The established genetic predisposition due to trisomy 21 is the primary driver of increased leukemia risk in this population.
• Further research may explore other potential etiological factors in Down syndrome-associated leukemia.